Showing 281-290 of 18069 results for "".
Adjustment to Diabetes Diagnosis / New Technology
https://reachmd.com/programs/clinicians-roundtable/adjustment-to-diabetes-diagnosis-new-technology/328/Dr. Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses adjustment to the diagnosis of Type 1 diabetes. ShOral Agents for Diabetes: What to Choose and When
https://reachmd.com/programs/diabetes-discourse/oral-agents-for-diabetes-what-to-choose-and-when/5340/We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as theThe Certified Diabetes Educator: A Key Role in the Diabetes Team
https://reachmd.com/programs/diabetes-discourse/the-certified-diabetes-educator-a-key-role-in-the-diabetes-team/5640/Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven EdelType1 Diabetes Cure Research & Autoimmune Diseases
https://reachmd.com/programs/clinicians-roundtable/type1-diabetes-cure-research-autoimmune-diseases/1772/Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.The Importance of Diabetes Education for Patients and Providers
https://reachmd.com/programs/diabetes-discourse/the-importance-of-diabetes-education-for-patients-and-providers/4846/The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. StevRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
https://reachmd.com/programs/medical-industry-feature/rethinking-diabetes-care-key-data-from-incorporating-lifestyle-modifications/14289/What role do lifestyle modifications have in managing obesity and type 2 diabetes? Find out.Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Obesity, Diabetes and the Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/obesity-diabetes-and-the-metabolic-syndrome/6706/Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or theThe Diabetes Infrastructure: Regulation & Reimbursement
https://reachmd.com/programs/diabetes-discourse/the-diabetes-infrastructure-regulation-reimbursement/4796/The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuCurrent Trends and Treatment Goals for Diabetes
https://reachmd.com/programs/focus-on-pharmacy/current-trends-and-treatment-goals-for-diabetes/3531/How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practice